Capivasertib Impurity 18 | CAS 28936-94-9 - Request Quote
Capivasertib Impurity 18
| SZ CAT No: | SZ-C254022 |
| CAS No | 28936-94-9 |
| Mol.F. | C14H17N3O2 |
| Mol.Wt. | 259.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Capivasertib Impurity 18 is chemically 8-benzyl-1,3,8-triazaspiro[4.5]decane-2,4-dione. Capivasertib Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Capivasertib Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capivasertib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 28936-94-9
Purchase 28936-94-9
Order 28936-94-9
Enquire 28936-94-9
price of 28936-94-9
28936-94-9 Supplier
28936-94-9 Manufacturer
28936-94-9 Exporter
buy high quality Capivasertib Impurity 18
Purchase Capivasertib Impurity 18
Capivasertib Impurity 18 suppliers
Capivasertib Impurity 18 manufacturers
Capivasertib Impurity 18 price
Order Capivasertib Impurity 18
Enquire Capivasertib Impurity 18
Capivasertib Impurity 18 cost
Capivasertib Impurity 18 Supplier
Capivasertib Impurity 18 Distributor
Capivasertib Impurity 18 for Method Validation
Capivasertib Reference Standard
Capivasertib Impurity 18 for ANDA Filing
Capivasertib Impurity 18 for Forced Degradation Studies
Capivasertib Impurity 18 Identification Standards
Capivasertib Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


